Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Paris Brain Institute, |
RCV001391578 | SCV001451350 | uncertain significance | Spastic paraplegia | criteria provided, single submitter | clinical testing | ||
Labcorp Genetics |
RCV001391578 | SCV004364922 | pathogenic | Spastic paraplegia | 2023-12-18 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Cys377Alafs*4) in the ZFYVE26 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in ZFYVE26 are known to be pathogenic (PMID: 18394578, 19805727). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with ZFYVE26-related conditions. ClinVar contains an entry for this variant (Variation ID: 989172). For these reasons, this variant has been classified as Pathogenic. |